Human embryonic stem cell derived islet progenitors mature inside an encapsulation device without evidence of increased biomass or cell escape

Stem Cell Research

Volumn 12, Issue 3, 2014, Pages 807-814

  Kirk, Kaitlyn ^a,b   Hao, Ergeng ^a,b   Lahmy, Reyhaneh ^a,b   Itkin Ansari, Pamela ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOXAN; C PEPTIDE; GLUCAGON; GLUCOSE; INSULIN;

ALLOXAN-INDUCED DIABETES MELLITUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; BIOLUMINESCENT IMAGING; BIOMASS; CELL DIFFERENTIATION; CELL ENCAPSULATION; CELL GROWTH; CELL MATURATION; CELL THERAPY; CELL VOLUME; CONTROLLED STUDY; EMBRYONIC STEM CELL; ENDOCRINE CELL; GENERAL MEDICAL DEVICE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLYCEMIC CONTROL; HISTOLOGY; HUMAN; HUMAN CELL; IMAGING AND DISPLAY; IMMUNITY; IMMUNOFLUORESCENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; TURNOVER TIME; ANIMAL; CELL PROLIFERATION; CHEMISTRY; CULTURE TECHNIQUE; CYTOLOGY; DEVICES; DIABETES MELLITUS; EVALUATION STUDY; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; PATHOPHYSIOLOGY; PROCEDURES; SECRETION (PROCESS); STAINING; TRANSPLANTATION;

ANIMALS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; DIABETES MELLITUS; EMBRYONIC STEM CELLS; HUMANS; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; STAINING AND LABELING;

EID: 84899532626     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2014.03.003     Document Type: Article

References (38)

1. Aguayo-Mazzucato C., Bonner-Weir S. Stem cell therapy for type 1 diabetes mellitus. Nat. Rev. Endocrinol. 2010, 6:139-148.
2. Brauker J.H., Carr-Brendel V.E., Martinson L.A., Crudele J., Johnston W.D., Johnson R.C. Neovascularization of synthetic membranes directed by membrane microarchitecture. J. Biomed. Mater. Res. 1995, 29:1517-1524.
3. Bruin J.E., Rezania A., Xu J., Narayan K., Fox J.K., O'Neil J.J., Kieffer T.J. Maturation and function of human embryonic stem cell-derived pancreatic progenitors in macroencapsulation devices following transplant into mice. Diabetologia 2013, 56:1987-1998.
4. Carr-Brendel V.E., Geller R.L., Thomas T.J., Boggs D.R., Young S.K., Crudele J., Martinson L.A., Maryanov D.A., Johnson R.C., Brauker J.H. Transplantation of cells in an immunoisolation device for gene therapy. Methods Mol. Biol. 1997, 63:373-387.
5. Cho C.H., Hannan N.R., Docherty F.M., Docherty H.M., Joåo Lima M., Trotter M.W., Docherty K., Vallier L. Inhibition of activin/nodal signalling is necessary for pancreatic differentiation of human pluripotent stem cells. Diabetologia 2012, 55(12):3284-3295. (Dec).
6. D'Amour K.A., Bang A.G., Eliazer S., Kelly O.G., Agulnick A.D., Smart N.G., Moorman M.A., Kroon E., Carpenter M.K., Baetge E.E. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat. Biotechnol. 2006, 24:1392-1401.
7. Itkin-Ansari P., Geron I., Hao E., Demeterco C., Tyrberg B., Levine F. Cell-based therapies for diabetes: progress towards a transplantable human beta cell line. Ann. N. Y. Acad. Sci. 2003, 1005:138-147.
8. Jenkins D.E., Oei Y., Hornig Y.S., Yu S.F., Dusich J., Purchio T., Contag P.R. Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. Clin. Exp. Metastasis 2003, 20(8):733-744.
9. Jiang J., Au M., Lu K., Eshpeter A., Korbutt G., Fisk G., Majumdar A.S. Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells 2007, 25:1940-1953.
10. Kelly O.G., Chan M.Y., Martinson L.A., Kadoya K., Ostertag T.M., Ross K.G., Richardson M., Carpenter M.K., D'Amour K.A., Kroon E., Moorman M., Baetge E.E., Bang A.G. Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells. Nat. Biotechnol. 2011, 29:750-756.
11. Kim J.B., Urban K., Cochran E., Lee S., Ang A., Rice B., Bata A., Campbell K., Coffee R., Gorodinsky A., Lu Z., Zhou H., Kishimoto T.K., Lassota P. Non-invasive detection of a small number of bioluminescent cancer cells in vivo. PLoS One 2010, 5(2):e9364.
12. Koro C.E., Bowlin S.J., Bourgeois N., Fedder D.O. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care 2004, (1):17-20.
13. Kroon E., Martinson L.A., Kadoya K., Bang A.G., Kelly O.G., Eliazer S., Young H., Richardson M., Smart N.G., Cunningham J., Agulnick A.D., D'Amour K.A., Carpenter M.K., Baetge E.E. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat. Biotechnol. 2008, 26:443-452.
14. Ku H.T., Zhang N., Kubo A., O'Connor R., Mao M., Keller G., Bromberg J.S. Committing embryonic stem cells to early endocrine pancreas in vitro. Stem Cells 2004, 22:1205-1217.
15. Kumagai-Braesch M., Jacobson S., Mori H., Jia X., Takahashi T., Wernerson A., Flodstrom-Tullberg M., Tibell A. The TheraCyte device protects against islet allograft. Cell Transplant. 2013, 238-251.
16. Lee S.H., Hao E., Savinov A.Y., Geron I., Strongin A.Y., Itkin-Ansari P. Human beta-cell precursors mature into functional insulin-producing cells in an immunoisolation device: implications for diabetes cell therapies. Transplantation 2009, 87:983-991.
17. Londrigan S.L., Brady J.L., Sutherland R.M., Hawthorne W.J., Thomas H.E., Jhala G., Cowan P.J., Kay T.W., O'Connell P.J., Lew A.M. Evaluation of promoters for driving efficient transgene expression in neonatal porcine islets. Xenotransplantation 2007, 14(2):119-125.
18. Loudovaris T., Jacobs S., Young S., Maryanov D., Brauker J., Johnson R.C. Correction of diabetic nod mice with insulinomas implanted within Baxter immunoisolation devices. J. Mol. Med. 1999, 77:219-222.
19. Matveyenko A.V., Georgia S., Bhushan A., Butler P.C. Inconsistent formation and nonfunction of insulin-positive cells from pancreatic endoderm derived from human embryonic stem cells in athymic nude rats. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E713-E720.
20. Mayhew C.N., Wells J.M. Converting human pluripotent stem cells into beta-cells: recent advances and future challenges. Curr. Opin. Organ Transplant. 2010, 15(1):54-60.
21. Rafael E., Wu G.S., Hultenby K., Tibell A., Wernerson A. Improved survival of macroencapsulated islets of Langerhans by preimplantation of the immunoisolating device: a morphometric study. Cell Transplant. 2003, 12:407-412.
22. Rezania A., Bruin J.E., Riedel M.J., Mojibian M., Asadi A., Xu J., Gauvin R., Narayan K., Karanu F., O'Neil J.J., Ao Z., Warnock G.L., Kieffer T.J. Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice. Diabetes 2012, 61:2016-2029.
23. Rezania A., Bruin J.E., Xu J., Narayan K., Fox J.K., O'Neil J.J., Kieffer T.J. Enrichment of human embryonic stem cell-derived NKX6.1-expressing pancreatic progenitor cells accelerates the maturation of insulin-secreting cells in vivo. Stem Cells 2013, 31:2432-2442.
24. Ryan E.A., Bigam D., Shapiro A.M. Current indications for pancreas or islet transplant. Diabetes Obes. Metab. 2006, 8:1-7.
25. Schulz T.C., Young H.Y., Agulnick A.D., Babin M.J., Baetge E.E., Bang A.G., Bhoumik A., Cepa I., Cesario R.M., Haakmeester C., Kadoya K., Kelly J.R., Kerr J., Martinson L.A., McLean A.B., Moorman M.A., Payne J.K., Richardson M., Ross K.G., Sherrer E.S., Song X., Wilson A.Z., Brandon E.P., Green C.E., Kroon E.J., Kelly O.G., D'Amour K.A., Robins A.J. A scalable system for production of functional pancreatic progenitors from human embryonic stem cells. PLoS One 2012, 7:e37004.
26. Shim J.H., Kim S.E., Woo D.H., Kim S.K., Oh C.H., McKay R., Kim J.H. Directed differentiation of human embryonic stem cells towards a pancreatic cell fate. Diabetologia 2007, 50:1228-1238.
27. Sweet I.R., Yanay O., Waldron L., Gilbert M., Fuller J.M., Tupling T., Lernmark A., Osborne W.R. Treatment of diabetic rats with encapsulated islets. J. Cell. Mol. Med. 2008, 12:2644-2650.
28. Tarantal A.F., Lee C.C., Itkin-Ansari P. Real-time bioluminescence imaging of macroencapsulated fibroblasts reveals allograft protection in rhesus monkeys (Macaca mulatta). Transplantation 2009, 88:38-41.
29. Tatarkiewicz K., Hollister-Lock J., Quickel R.R., Colton C.K., Bonner-Weir S., Weir G.C. Reversal of hyperglycemia in mice after subcutaneous transplantation of macroencapsulated islets. Transplantation 1999, 67:665-671.
30. Tibell A., Rafael E., Wennberg L., Nordenstrom J., Bergstrom M., Geller R.L., Loudovaris T., Johnson R.C., Brauker J.H., Neuenfeldt S., Wernerson A. Survival of macroencapsulated allogeneic parathyroid tissue one year after transplantation in nonimmunosuppressed humans. Cell Transplant. 2001, 10:591-599.
31. Tyrberg B., Andersson A., Borg L.A. Species differences in susceptibility of transplanted and cultured pancreatic islets to the beta-cell toxin alloxan. Gen. Comp. Endocrinol. 2001, 122.
32. Ryan E.A., Bigam D., Shapiro A.M. Current indications for pancreas or islet transplant. Diabetes Obes. Metab. 2006, 8:1-7.
33. Van Hoof D., D'Amour K.A., German M.S. Derivation of insulin-producing cells from human embryonic stem cells. Stem Cell Res. 2009, 3:73-87.
34. Volk-Draper L.D., Rajput S., Hall K.L., Wilber A., Ran S. Novel model for basaloid triple-negative breast cancer: behavior in vivo and response to therapy. Neoplasia 2012, 14(10):926-942.
35. Xie B.W., Mol I.M., Keereweer S., van Beek E.R., Que I., Snoeks T.J., Chan A., Kaijzel E.L., Lowik C.W. Dual-wavelength imaging of tumor progression by activatable and targeting near-infrared fluorescent probes in a bioluminescent breast cancer model. PLoS One 2012, 7(2):e31875.
36. Yakhnenko I., Wong W.K., Katkov I.I., Itkin-Ansari P. Cryopreservation of human insulin expressing cells macro-encapsulated in a durable therapeutic immunoisolating device theracyte. Cryo Letters 2012, 33:518-531.
37. Ryan E.A., Bigam D., Shapiro A.M. Current indications for pancreas or islet transplant. Diabetes Obes. Metab. 2006, 8:1-7.
38. Zhang D., Jiang W., Liu M., Sui X., Yin X., Chen S., Shi Y., Deng H. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res. 2009, 19(4):429-438.